시장보고서
상품코드
1182902

세계의 신경 혈전 제거 기기 시장 : 제품별, 치료 용도별, 최종 용도별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측, 신형 코로나바이러스(COVID-19)의 영향(2022-2028년)

Neurothrombectomy Devices Market with COVID-19 Impact Analysis, By Product, By Therapeutic Applications, By End-Use, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 333 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신경 혈전 제거 기기 시장 규모는 2021년에 7억 8,050만 달러에 이르고, 2022-2028년 12.7%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다.

세계의 신경 혈전 제거 기기(Neurothrombectomy Devices) 시장을 분석했으며, 시장의 정의와 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 업계 경쟁력과 매력, 시장 점유율 구조, 제품별·치료 용도별·최종 용도별·지역별 시장 동향 전망, 주요 기업 개요, 신형 코로나바이러스(COVID-19)의 영향 등의 정보를 전해드립니다.

목차

제1장 신경 혈전 제거 기기 시장 개요

제2장 주요 요약

제3장 신경 혈전 제거 기기 시장 : 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 신경 혈전 제거 기기 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 프레임워크 분석

제5장 신경 혈전 제거 기기 시장 : 신형 코로나바이러스(COVID-19)의 영향 분석

  • 코로나 이전의 영향 분석
  • 코로나 이후의 영향 분석

제6장 신경 혈전 제거 기기 시장 : 시장 환경

  • 시장 점유율 분석(2021년)
  • 주요 기술 혁신 기업 분석
  • 시장 구분 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신규 기업 분석

제7장 신경 혈전 제거 기기 시장 : 제품별

  • 개요

제8장 신경 혈전 제거 기기 시장 : 치료 용도별

  • 개요

제9장 신경 혈전 제거 기기 시장 : 최종 용도별

  • 개요

제10장 신경 혈전 제거 기기 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양(APAC)
  • 라틴아메리카
  • 중동 및 아프리카

제11장 신경 혈전 제거 기기 시장 : 주요 벤더 분석

  • 경쟁 대시보드
  • 기업 개요
    • Edwards Lifesciences Corporation
    • Phenox GmbH
    • Vesalio, LLC
    • Penumbra, Inc
    • Acandis GmbH
    • Koninklijke Philips N.V.
    • ARGON MEDICAL
    • Stryker Corporation
    • Medtronic Pic
    • Boston Scientific Corporation
    • W.L. Gore & Associatess, Inc.
    • Terumo Corporation
    • Microport Scientific Corporation
    • Teleflex Incorporated

제12장 AnalystView 전방위적 분석

제13장 부록

LSH 23.01.19

REPORT HIGHLIGHT

Neurothrombectomy Devices Market size was valued at USD 780.5 Million in 2021, expanding at a CAGR of 12.7% from 2022 to 2028.

A neurothrombectomy device is used in treating ischemic stroke. Additionally, it is carried out using mechanical, laser, and ultrasound technologies to remove blood clots. It also helps in reducing patient mortality rate and improves functional outcomes. Neurothrombectomy devices are of two Therapeutic Applications aspiration and clot retrieval devices. Moreover, it is mainly used to treat big vascular occlusions more effectively, achieve recanalization quickly, and reduce the likelihood of hemorrhagic events

Market Dynamics:

The growing concern about chronic disease and rising unhealthy lifestyle habits of individuals such as smoking, unhealthy food, and lack of exercise are liable for ischemic stroke increasing cases. Additionally, as compared to older adults stroke is more complex in young adults that projected to drive the neurothrombectomy devices market growth. However, the high cost allied with neurothrombectomy devices is expected to hamper the mar growth.

Furthermore, Moreover, for the treatment of AIS (acute ischemic strokes.) and its symptoms, neurothrombectomy devices adopt new technologies such as fourth-generation solitaire X revascularization devices. Thereby such advanced technologies will propel the neurothrombectomy devices market growth. The COVID-19 pandemic had a devastating effect on the neurothrombectomy devices market and directly impacts the demand and production, disrupting the supply chain, and raising the financial burden on firms. Brain surgeries have been postponed or even canceled to prevent the coronavirus spread.

Segmentation Analysis:

The neurothrombectomy devices market is segmented on the basis of product, Therapeutic Applications, end-use, and by region.

The market is divided into three categories based on product: clot retrievers, aspiration/suction devices, and vascular snares. The aspiration/suction devices segment is expected to possess market growth during the forecast period due to physicians increasing preference. In addition, due to the increased prevalence of neurological disorders among people, the aspiration/suction devices segment is propelling the market growth.

The market is divided into three categories based on therapeutic applications: stenosis, ischemic strokes, brain aneurysms, and others. The ischemic stroke segment is expected to dominate the market share. The rising cases of ischemic strokes due to unhealthy lifestyles are contributing to the segment growth during the forecast period.

The market is divided into three categories based on end-use: hospitals, emergency clinics, and ambulatory surgical centers. The ambulatory surgical centers segment is estimated to grow during the forecast period. In ASCs half of the outpatient surgeries are performed such as acute ischemic disease surgical treatment, in this condition the treatment is required to be performed within 6 hours of symptom onset. Thus, by ASCs a shorter waiting time offered to the patient further drives the segment growth.

Competitive Landscape:

To enable the extraction of thrombus safely from patients dealing with acute ischemic disorders, a neurothrombectomy device is specially designed for physicians. Penumbra represents a significant improvement in performance with the launch of this device and helps patients suffering from acute ischemic disorders. Additionally, new strategies are adopted by market players such as marketing, promotions, partnerships, collaborations, mergers, and new product launches. To increase the availability and outreach of their product offerings the companies are using broadening product portfolios widely.

For instance, in June 2021, Penumbra Receives FDA clearance for RED 62 Reperfusion Catheter with optimized tractability to navigate the complex vessel anatomy for the removal of blood clots in the brain and deliver powerful aspiration.

Key features of the study:

  • This proposed research study on neurothrombectomy devices market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for neurothrombectomy devices market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the neurothrombectomy devices market.
  • Impact of COVID-19 on neurothrombectomy devices market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on neurothrombectomy devices market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the neurothrombectomy devices market, we have also included competitive landscape and key innovator analysis for the neurothrombectomy devices market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the neurothrombectomy devices market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global neurothrombectomy devices market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

NEUROTHROMBAETOMY DEVICES MARKET KEY PLAYERS

  • Edwards Lifesciences Corporation
  • Phenox GmbH
  • Vesalio, LLC
  • Penumbra, Inc
  • Acandis GmbH
  • Koninklijke Philips N.V.
  • ARGON MEDICAL
  • Stryker Corporation
  • Medtronic Pic
  • Boston Scientific Corporation
  • W.L. Gore & Associatess, Inc.
  • Terumo Corporation
  • Microport Scientific Corporation
  • Teleflex Incorporated

NEUROTHROMBECTOMY DEVICES MARKET, BY PRODUCT

  • Clot Retrievers
  • Aspiration/Suction Devices
  • Vascular Snares

NEUROTHROMBECTOMY DEVICES MARKET, BY THERAPEUTIC APPLICATIONS

  • Brain Aneurysm
  • Stenosis
  • Ischemic Strokes
  • Others

NEUROTHROMBECTOMY DEVICES MARKET, BY END-USE

  • Hospitals
  • Emergency Clinics
  • Ambulatory Surgical Centers

NEUROTHROMBECTOMY DEVICES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT

1. Neurothrombectomy Devices Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurothrombectomy Devices Market Snippet by Product
    • 2.1.2. Neurothrombectomy Devices Market Snippet by Therapeutic Applications
    • 2.1.3. Neurothrombectomy Devices Market Snippet by End-Use
    • 2.1.4. Neurothrombectomy Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurothrombectomy Devices Key Market Trends

  • 3.1. Neurothrombectomy Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurothrombectomy Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurothrombectomy Devices Market Opportunities
  • 3.4. Neurothrombectomy Devices Market Future Trends

4. Neurothrombectomy Devices Market Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurothrombectomy Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neurothrombectomy Devices Market Landscape

  • 6.1. Neurothrombectomy Devices Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurothrombectomy Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2021&2028 (%)
    • 7.1.2. Clot Retrievers
    • 7.1.3. Aspiration/Suction Devices
    • 7.1.4. Vascular Snares

8. Neurothrombectomy Devices Market - By Therapeutic Applications

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Applications, 2021&2028 (%)
    • 8.1.2. Brain Aneurysm
    • 8.1.3. Stenosis
    • 8.1.4. Ischemic Strokes
    • 8.1.5. Others

9. Neurothrombectomy Devices Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2021&2028 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Emergency Clinics
    • 9.1.4. Ambulatory Surgical Centers

10. Neurothrombectomy Devices Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2021&2028 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Neurothrombectomy Devices Market Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Neurothrombectomy Devices Market Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Neurothrombectomy Devices Market Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.14.4. PhilippinesMarket Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.14.5. PhilippinesMarket Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Neurothrombectomy Devices Market Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Neurothrombectomy Devices Market Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.9.3. IsraelMarket Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.9.4. IsraelMarket Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.9.5. IsraelMarket Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Applications, 2017 - 2028 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)

11. Key Vendor Analysis- Neurothrombectomy Devices Market Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Edwards Lifesciences Corporation
    • 11.2.2. Phenox GmbH
    • 11.2.3. Vesalio, LLC
    • 11.2.4. Penumbra, Inc
    • 11.2.5. Acandis GmbH
    • 11.2.6. Koninklijke Philips N.V.
    • 11.2.7. ARGON MEDICAL
    • 11.2.8. Stryker Corporation
    • 11.2.9. Medtronic Pic
    • 11.2.10. Boston Scientific Corporation
    • 11.2.11. W.L. Gore & Associatess, Inc.
    • 11.2.12. Terumo Corporation
    • 11.2.13. Microport Scientific Corporation
    • 11.2.14. Teleflex Incorporated

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제